Health authorities could give a green light for emergency use within weeks, which would mark the most rapid vaccine development for a pandemic in history -- but many questions remain
AstraZeneca Plc and the University of Oxford face mounting questions about their Covid-19 vaccine trial results after acknowledging a manufacturing error
If regulators approve any of the vaccines in coming weeks, the companies have said distribution could begin almost immediately with governments around the world to decide who gets them and in what order. The following is an outline of the process
A top European Union official said the first citizens in the bloc could be vaccinated against the coronavirus by Christmas, but she warned that member countries must urgently prepare their logistical chains for the rollout of hundreds of millions of doses of the vaccines
The vaccine, known as BNT162b2, will be tested on volunteers at the Jiangsu Provincial Center for Disease Control and Prevention to assess safety and immunogenicity, eyeing future approval in China
A health department team has been deployed at the airport for testing passengers coming from Delhi
Russian virus vaccine to cost less than USD 10 per dose abroad
BoE considered a plausible worst-case scenario of an infected person coughing or sneezing onto a note and found that the level of virus on the surface began to drop rapidly after an hour. After six hours, it had declined to 5% or less
Vir Biotech’s medicine is unique because it targets a variety of coronaviruses, CEO George Scangos
The leader of the US govt’s coronavirus vaccine program said AstraZeneca found that 16 participants who received a placebo in its clinical trial contracted severe Covid-19, a sign that the shot could block the worst cases of disease
India registered less than 40,000 fresh coronavirus cases in a span of 24 hours after 6 days. Since Nov 8, the number of daily cases has been sustained below the 50,000-mark, health ministry said.
